FindTrial
Sign In

The Hemoglobin data collection study from hemoglobin monitoring device developed by Bosch

An open-label, Single arm, cross sectional, non-randomized data collection study to develop hemoglobin algorithm, from data collected from non-invasive hemoglobin monitoring device developed by Bosch and gold standard (calibrated blood cell counter). - TI-HB-2022-01

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042535
Enrollment
750
Registered
2022-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R798- Other specified abnormal findingsof blood chemistry

Interventions

Intervention1: NIL: NIL

Sponsors

Robert Bosch Engineering and Business Solutions Private Limited
Lead Sponsor
Thinki Unit of Tenet Health Edutech Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or Female patients with age of eighteen (18) and above. 2. Able to give written informed consent. 3. Finger size: 8 mm to 23 mm (The device is designed to fit this range of finger size) and index finger preferred to monitor.

Exclusion criteria

Exclusion criteria: 1. Patients with paronychia, fungal infections of the nail bed, blistering disorders involving the fingers, hyper-keratosis.

Design outcomes

Primary

MeasureTime frame
The objective of this is to collect the data, use the data to train the algorithm to derive the Hb value post this data collection activity.Timepoint: Baseline, Day 1—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDevesh Kumar

Think-i, Unit of Tenet Health Edutech Pvt. Ltd.

dr.devesh.kumar@thinki.in7827758840

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026